PMID- 14581146
OWN - NLM
STAT- MEDLINE
DCOM- 20040712
LR  - 20211203
IS  - 0168-8227 (Print)
IS  - 0168-8227 (Linking)
VI  - 62
IP  - 2
DP  - 2003 Nov
TI  - Higher prevalence of type 2 diabetes, metabolic syndrome and cardiovascular 
      diseases in gypsies than in non-gypsies in Slovakia.
PG  - 95-103
AB  - OBJECTIVE: Gypsies (or Roma) recently experienced a transition from a traditional 
      to a Westernized lifestyle. Although mortality in this population is 4-fold 
      higher compared with non-Gypsies, very limited information is available on their 
      morbidity especially with regard to non-communicable diseases. Our aim was to 
      determine the prevalence of type 2 diabetes mellitus (T2DM), metabolic syndrome 
      and cardiovascular diseases in Gypsies and non-Gypsies living in the same region 
      of southern Slovakia. MATERIALS AND METHODS: We examined 156 Gypsies and 501 
      non-Gypsies who participated in a population survey. Age- and sex-standardized 
      prevalence rates were computed for each of the following: T2DM, obesity, 
      hyperlipidemia, hypertension, hyperinsulinemia, elevated albumin/creatinine ratio 
      (ACR), metabolic syndrome and cardiovascular disease. RESULTS: Age-sex 
      standardized prevalence of T2DM was 30% (95% CI=22-39) in Gypsies and 10% (8-13, 
      P=0.0001 for comparison of ethnic groups) in non-Gypsies. Corresponding 
      prevalence of the other variables are: 65% (56-74) and 30% (26-34, P=0.0001) for 
      obesity, 69% (61-76) and 59% (54-63, P=0.04) for hypercholesterolemia, 66% 
      (59-74) and 39% (35-43, P=0.009) for hypertriglyceridemia, 49% (42-56) and 43% 
      (39-47, P=0.1) for hypertension, 33% (26-50) and 8% (2-14, P=0.002) for 
      hyperinsulinemia, 16% (9-22) and 5% (3-7, P=0.0001) for elevated ACR, 20% (12-27) 
      and 4% (3-6, P=0.0001) for metabolic syndrome and 35% (28-43) and 26% (22-29, 
      P=0.004) for cardiovascular disease. CONCLUSIONS: Compared with non-Gypsies, 
      Gypsies had a much higher prevalence of T2DM, metabolic syndrome and 
      cardiovascular disease, which may contribute to their higher mortality.
FAU - Vozarova de Courten, Barbora
AU  - Vozarova de Courten B
AD  - Clinical Diabetes and Nutrition Section, National Institute of Diabetes and 
      Digestive and Kidney Diseases, National Institutes of Health, 4212 N, 16th 
      Street, Rm. 5-41, Phoenix, AZ 85016, USA. bvozarov@mail.nih.gov
FAU - de Courten, Maximilian
AU  - de Courten M
FAU - Hanson, Robert L
AU  - Hanson RL
FAU - Zahorakova, Alena
AU  - Zahorakova A
FAU - Egyenes, Henry P
AU  - Egyenes HP
FAU - Tataranni, P Antonio
AU  - Tataranni PA
FAU - Bennett, Peter H
AU  - Bennett PH
FAU - Vozar, Juraj
AU  - Vozar J
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Ireland
TA  - Diabetes Res Clin Pract
JT  - Diabetes research and clinical practice
JID - 8508335
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Cardiovascular Diseases/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Diabetes Mellitus/epidemiology
MH  - Diabetes Mellitus, Type 2/*epidemiology
MH  - *Ethnicity
MH  - Female
MH  - Humans
MH  - Hypercholesterolemia/epidemiology
MH  - Male
MH  - Metabolic Syndrome/*epidemiology
MH  - Middle Aged
MH  - Obesity/epidemiology
MH  - Slovakia/epidemiology
EDAT- 2003/10/29 05:00
MHDA- 2004/07/13 05:00
CRDT- 2003/10/29 05:00
PHST- 2003/10/29 05:00 [pubmed]
PHST- 2004/07/13 05:00 [medline]
PHST- 2003/10/29 05:00 [entrez]
AID - S0168822703001621 [pii]
AID - 10.1016/s0168-8227(03)00162-1 [doi]
PST - ppublish
SO  - Diabetes Res Clin Pract. 2003 Nov;62(2):95-103. doi: 
      10.1016/s0168-8227(03)00162-1.